Current concepts surrounding bone health and osteoporosis in Turner syndrome

References

• Bondy CA; Turner Syndrome Study Group. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007;92(1):10-25
   PubMed Web of Science ®Google Scholar
• Sybert VP, McCauley E. Turner’s syndrome. N Engl J Med 2004;351(12):1227-38
   PubMed Web of Science ®Google Scholar
• Turner HH. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938;23(5):566-74
   Google Scholar
• Bechtold S, Rauch F, Noelle V, et al. Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 2001;86(12):5819-23
   Google Scholar
• Soucek O, Lebl J, Snajderova M, et al. Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages. Clin Endocrinol (Oxf) 2011;74(4):445-52
   Google Scholar
• Bakalov V, Axelrod L, Baron J, et al. Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab 2003;88(12):5717-22
   PubMed Web of Science ®Google Scholar
• Rauch F, Schoenau E. The developing bone: slave or master of its cells and molecules? Pediatr Res 2001;50(3):309-14
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Hjerrild BE, Mosekilde L, et al. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol 2006;155(4):583-92
   PubMed Web of Science ®Google Scholar
• Ross JL, Kushner H, Roeltgen DP. Developmental changes in motor function in girls with Turner syndrome. Pediatr Neurol 1996;15(4):317-22
   Google Scholar
• Saad K, Abdelrahman AA, Abdel-Raheem YF, et al. Turner syndrome: review of clinical, neuropsychiatric, and EEG status: an experience of tertiary center. Acta Neurol Belg 2014;114(1):1-9
   Google Scholar
• Salbenblatt JA, Meyers DC, Bender BG, et al. Gross and fine motor development in 45, X and 47, XXX girls. Pediatrics 1989;84(4):678-82
   Google Scholar
• Wells G, O’Gorman C, Rayner T, et al. Skeletal muscle abnormalities in girls and adolescents with Turner syndrome. Miscellaneous article J Clin Endocrinol 2013;98(6):2521-7
   Google Scholar
• Heinonen A, Mäntynen J, Kannus P, et al. Effects of high-impact training and detraining on femoral neck structure in premenopausal women: a hip structural analysis of an 18-month randomized controlled exercise intervention with 3.5-year follow-up. Physiothérapie Can 2012;64(1):98-105
   Google Scholar
• Daly RM, Bass SL. Lifetime sport and leisure activity participation is associated with greater bone size, quality and strength in older men. Osteoporos Int J 2006;17(8):1258-67
   PubMed Web of Science ®Google Scholar
• Jackowski SA, Kontulainen SA, Cooper DM, et al. Adolescent physical activity and bone strength at the proximal femur in adulthood. Med Sci Sports Exerc 2014;46(4):736-44
   PubMed Web of Science ®Google Scholar
• Lloyd T, Chinchilli VM, Johnson-Rollings N, et al. Adult female hip bone density reflects teenage sports-exercise patterns but not teenage calcium intake. Pediatrics 2000;106(1 Pt 1):40-4
   Google Scholar
• Naeraa RW, Brixen K, Hansen RM, et al. Skeletal size and bone mineral content in Turner’s syndrome: relation to karyotype, estrogen treatment, physical fitness, and bone turnover. Calcif Tissue Int 1991;49(2):77-83
   Google Scholar
• Cavallo L, Gurrado R. Endogenous growth hormone secretion does not correlate with growth in patients with Turner’s syndrome. Italian Study Group for Turner Syndrome. J Pediatr Endocrinol Metab 1999;12(5):623-7
   PubMed Web of Science ®Google Scholar
• Pirazzoli P, Mazzanti L, Bergamaschi R, et al. Reduced spontaneous growth hormone secretion in patients with Turner’s syndrome. Acta Paediatr 88(6):610-13
   Google Scholar
• Ross JL, Long LM, Loriaux DL, Cutler GB Jr. Growth hormone secretory dynamics in Turner syndrome. J Pediatr 1985;106(2):202-6
   Google Scholar
• Ranke MB, Blum WF, Haug F, et al. Growth hormone, somatomedin levels and growth regulation in Turner’s syndrome. Acta Endocrinol (Copenh) 1987;116(3):305-13
   Google Scholar
• Gravholt CH. Epidemiological, endocrine and metabolic features in Turner syndrome. Eur J Endocrinol 2004;151(6):657-87
   PubMed Web of Science ®Google Scholar
• Cleemann L, Holm K, Kobbernagel H, et al. Normal tempo of bone formation in Turner syndrome despite signs of accelerated bone resorption. Horm Res Paediatr 2011;76(3):193-201
   Google Scholar
• Gravholt C, Lauridsen A, Brixen K, et al. Marked disproportionality in bone size and mineral and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome: a cross-sectional study. J Clin Endocrinol Metab 2002;87(6):2798-808
   PubMed Web of Science ®Google Scholar
• Ranke MB, Pflüger H, Rosendahl W, et al. Turner syndrome: spontaneous growth in 150 cases and review of the literature. Eur J Pediatr 1983;141(2):81-8
   Google Scholar
• Rongen-Westerlaken C, Corel L, van den Broeck J, et al. Reference values for height, height velocity and weight in Turner’s syndrome. Swedish Study Group for GH treatment. Acta Paediatr 86(9):937-42
   Google Scholar
• Munns CJF, Haase HR, Crowther LM, et al. Expression of SHOX in human fetal and childhood growth plate. J Clin Endocrinol Metab 2004;89(8):4130-5
   Google Scholar
• Marchini A, Marttila T, Winter A, et al. The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes. J Biol Chem 2004;279(35):37103-14
   Google Scholar
• Soucek O, Zapletalova J, Zemkova D, et al. Prepubertal girls with Turner syndrome and children with isolated SHOX deficiency have similar bone geometry at the radius. J Clin Endocrinol Metab 2013;98(7):E1241-7
   PubMed Web of Science ®Google Scholar
• Bakalov VK, Van PL, Baron J, et al. Growth hormone therapy and bone mineral density in Turner syndrome. J Clin Endocrinol Metab 2004;89(10):4886-9
   Google Scholar
• Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf) 1999;51(4):497-502
   PubMed Web of Science ®Google Scholar
• Carrascosa A, Gussinye M, Terradas P, et al. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res 2000;15(10):2005-10
   PubMedGoogle Scholar
• NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285(6):785-95
   PubMed Web of Science ®Google Scholar
• Kanis JA, Melton LJ, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res 1994;9(8):1137-41
   PubMed Web of Science ®Google Scholar
• Papaioannou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010;182(17):1864-73
   PubMed Web of Science ®Google Scholar
• Ross JL, Long LM, Feuillan P, et al. Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner’s syndrome. J Clin Endocrinol Metab 1991;73(2):355-9
   Google Scholar
• Neely EK, Marcus R, Rosenfeld RG, Bachrach LK. Turner syndrome adolescents receiving growth hormone are not osteopenic. J Clin Endocrinol Metab 1993;76(4):861-6
   Google Scholar
• Lanes R, Gunczler P, Paoli M, Weisinger JR. Bone mineral density of prepubertal age girls with Turner’s syndrome while on growth hormone therapy. Horm Res 1995;44(4):168-71
   Google Scholar
• Shaw N, Rehan V, Husain S, et al. Bone mineral density in Turner’s syndrome - a longitudinal study. Clin Endocrinol (Oxf) 1997;47(3):367-70
   Google Scholar
• Freriks K, Timmermans J, Beerendonk CC, et al. Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome. J Clin Endocrinol Metab 2011;96(9):E1517-26
   PubMed Web of Science ®Google Scholar
• Hogler W, Briody J, Moore B, et al. Importance of estrogen on bone health in turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. J Clin Endocrinol Metab 2004;89(1):193-9
   Google Scholar
• Bakalov VK, Chen ML, Baron J, et al. Bone mineral density and fractures in Turner syndrome. Am J Med 2003;115(4):259-64
   Google Scholar
• Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998;51(2):147-58
   PubMed Web of Science ®Google Scholar
• Gravholt CH, Vestergaard P, Hermann AP, et al. Increased fracture rates in Turner’s syndrome: a nationwide questionnaire survey. Clin Endocrinol (Oxf) 2003;59(1):89-96
   Google Scholar
• Han TS, Cadge B, Conway GS. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner’s syndrome. Clin Endocrinol (Oxf) 2006;65(5):643-7
   PubMed Web of Science ®Google Scholar
• Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312(7041):1254-9
   PubMed Web of Science ®Google Scholar
• Conway GS, Band M, Doyle J, Davies MC. How do you monitor the patient with Turner’s syndrome in adulthood? Clin Endocrinol (Oxf) 2010;73(6):696-9
   Google Scholar
• Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry data. J Bone Miner Res 1992;7(2):137-45
   PubMed Web of Science ®Google Scholar
• Katzman DK, Bachrach LK, Carter DR, Marcus R. Clinical and anthropometric correlates of bone mineral acquisition in healthy adolescent girls. J Clin Endocrinol Metab 1991;73(6):1332-9
   Google Scholar
• Kröger H, Vainio P, Nieminen J, Kotaniemi A. Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone 1995;17(2):157-9
   Google Scholar
• Pors Nielsen S, Kolthoff N, Bärenholdt O, et al. Diagnosis of osteoporosis by planar bone densitometry: can body size be disregarded? Br J Radiol 1998;71(849):934-43
   Google Scholar
• Van der Sluis IM, de Ridder MA, Boot AM, et al. Reference data for bone density and body composition measured with dual energy X ray absorptiometry in white children and young adults. Arch Dis Child 2002;87(4):341-7
   Google Scholar
• Bertelloni S, Cinquanta L, Baroncelli GI, et al. Volumetric bone mineral density in young women with Turner’s syndrome treated with estrogens or estrogens plus growth hormone. Horm Res 2000;53(2):72-6
   Google Scholar
• Adams JE. Advances in bone imaging for osteoporosis. Nat Rev Endocrinol 2013;9(1):28-42
   PubMed Web of Science ®Google Scholar
• Holroyd CR, Davies JH, Taylor P, et al. Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome. Osteoporos Int J 2010;21(12):2093-9
   Google Scholar
• Hansen S, Brixen K, Gravholt CH. Compromised trabecular microarchitecture and lower finite element estimates of radius and tibia bone strength in adults with turner syndrome: a cross-sectional study using high-resolution–pQCT. J Bone Miner Res 2012;27(8):1794-803
   Google Scholar
• Nour MA. Impact of growth hormone on adult bone quality in Turner syndrome - a high resolution peripheral quantitative computed tomography study. 2014. Available from: http://theses.ucalgary.ca/handle/11023/1363
   Google Scholar
• Abate M, Vanni D, Pantalone A, Salini V. Cigarette smoking and musculoskeletal disorders. Muscles Ligaments Tendons J 2013;3(2):63-9
   PubMedGoogle Scholar
• Nachtigall MJ, Nazem TG, Nachtigall RH, Goldstein SR. Osteoporosis risk factors and early life-style modifications to decrease disease burden in women. Clin Obstet Gynecol 2013;56(4):650-3
   Google Scholar
• Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet 2014;383(9912):146-55
   PubMed Web of Science ®Google Scholar
• Peralta López M, Miras M, Silvano L, et al. Vitamin D receptor genotypes are associated with bone mass in patients with Turner syndrome. J Pediatr Endocrinol Metab 2011;24(5-6):307-12
   Google Scholar
• Peralta López M, Centeno V, Miras M, et al. Association of vitamin D receptor gene Cdx2 polymorphism with bone markers in Turner syndrome patients. J Pediatr Endocrinol Metab 2012;25(7-8):669-71
   Google Scholar
• Cleemann L, Hjerrild BE, Lauridsen AL, et al. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome. Eur J Endocrinol 2009;161(2):251-7
   PubMed Web of Science ®Google Scholar
• Davies MC, Gulekli B, Jacobs HS. Osteoporosis in Turner’s syndrome and other forms of primary amenorrhoea. Clin Endocrinol (Oxf) 1995;43(6):741-6
   Google Scholar
• Hanton L, Axelrod L, Bakalov V, Bondy CA. The importance of estrogen replacement in young women with Turner syndrome. J Womens Health (Larchmt) 12(10):971-7
   Google Scholar
• Kodama M, Komura H, Kodama T, et al. Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients. Endocr J 2012;59(2):153-9
   Google Scholar
• Crofton PM, Evans N, Bath LE, et al. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. Clin Endocrinol (Oxf) 2010;73(6):707-14
   PubMed Web of Science ®Google Scholar
• Nabhan ZM, Dimeglio LA, Qi R, et al. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. J Clin Endocrinol Metab 2009;94(6):2009-14
   Google Scholar
• Torres-Santiago L, Mericq V, Taboada M, et al. Metabolic effects of oral versus transdermal 17β-estradiol (E2): a randomized clinical trial in girls with Turner syndrome. J Clin Endocrinol Metab 2013;98(7):2716-24
   Google Scholar
• Stephure DK. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab 2005;90(6):3360-6
   Google Scholar
• Suganuma N, Furuhashi M, Hirooka T, et al. Bone mineral density in adult patients with Turner’s syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocr J 2003;50(3):263-9
   PubMed Web of Science ®Google Scholar
• Aycan Z, Cetinkaya E, Darendeliler F, et al. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial. Clin Endocrinol (Oxf) 2008;68(5):769-72
   Google Scholar
• Ari M, Bakalov VK, Hill S, Bondy CA. The effects of growth hormone treatment on bone mineral density and body composition in girls with turner syndrome. J Clin Endocrinol Metab 2006;91(11):4302-5
   Google Scholar
• Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, et al. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner’s syndrome participating in a randomized dose-response study. Pediatr Res 2001;50(3):417-22
   Google Scholar
• Estrada K, Styrkarsdottir U, Evangelou E, et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012;44(5):491-501
   PubMed Web of Science ®Google Scholar